Key result
IVUS-guided PCI with OPTIVUS criteria is linked to ~13-point lower 1-year major events vs historical PCI.
Cohort (n=3,485)
Yes
Answers are grounded in this paper and cite their sources.
Propensity-matched study reveals lower 1-year adverse event rates with optimal IVUS-guided PCI in multivessel disease, suggesting superiority over historical PCI or CABG.
BACKGROUND: There is a paucity of data on the effect of optimal intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) compared with standard PCI or coronary artery bypass grafting (CABG) in patients with multivessel disease. METHODS AND RESULTS: The OPTIVUS-Complex PCI study multivessel cohort was a prospective multicenter single-arm study enrolling 1,021 patients undergoing multivessel PCI including the left anterior descending coronary artery using IVUS aiming to meet the prespecified criteria for optimal stent expansion. We conducted propensity score matching analyses between the OPTIVUS group and historical PCI or CABG control groups from the CREDO-Kyoto registry cohort-3 (1,565 and 899 patients) fulfilling the inclusion criteria for this study. The primary endpoint was a composite of death, myocardial infarction, stroke, or any coronary revascularization. In the propensity score-matched cohort (OPTIVUS vs. historical PCI control: 926 patients in each group; OPTIVUS vs. historical CABG control: 436 patients in each group), the cumulative 1-year incidence of the primary endpoint was significantly lower in the OPTIVUS group than in the historical PCI control group (10.4% vs. 23.3%; log-rank P<0.001) or the historical CABG control group (11.8% vs. 16.5%; log-rank P=0.02). CONCLUSIONS: IVUS-guided PCI targeting the OPTIVUS criteria combined with contemporary clinical practice was associated with superior clinical outcomes at 1 year compared with not only the historical PCI control, but also the historical CABG control.
No takes yet. Share an insight, caveat, or question.
Yamamoto et al. (2023) conducted a cohort in Multivessel coronary artery disease (n=3,485). Optimal IVUS-guided PCI targeting OPTIVUS criteria vs. Historical PCI or CABG controls from the CREDO-Kyoto registry cohort-3 was evaluated on Composite of death, myocardial infarction, stroke, or any coronary revascularization (p=<0.001). IVUS-guided PCI targeting OPTIVUS criteria lowered 1-year composite events vs historical PCI and CABG controls.
Synapse has enriched 10 related papers. Consider them for comparative context: